Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
Fierce Biotech's 2025 Fierce 15
From advancing radically new therapies to refining existing modalities, this year’s Fierce 15 companies are pushing the envelope and giving us a reason for optimism.
Gabrielle Masson
Sep 22, 2025 8:00am
Sponsored
Getting to Yes: How Deal-Making Fuels Biotech Growth
Sep 17, 2025 3:20pm
Big Pharma-backed MapLight plots IPO
Sep 22, 2025 1:57pm
Angelini signs $550M-plus neuro pact with South Korean biotech
Sep 22, 2025 1:47pm
PacBio launches carrier screening panel in reproductive health
Sep 22, 2025 11:00am
Ionis rare disease candidate ekes out phase 3 win
Sep 22, 2025 10:46am
More News
Roche unveils strategy to become 'top 3' obesity company
Sep 22, 2025 8:05am
Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline
Sep 22, 2025 7:47am
Roche reports phase 3 breast cancer victory for oral SERD
Sep 22, 2025 7:25am
Fierce Pharma
Nominations open for Fiercest Women in Life Sciences—FINAL WEEK
Sep 22, 2025 7:00am
See more stories
